Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Operable Breast Neoplasms”

201 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 201 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT01937117
What this trial is testing

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Large-scale testing (Phase 3)Study completedNCT00002707
What this trial is testing

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

Who this might be right for
Breast Cancer
NSABP Foundation Inc 2,411
Large-scale testing (Phase 3)Ended earlyNCT01608451
What this trial is testing

Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast Cancer

Who this might be right for
Locally Advanced Breast Cancer and Large Operable Breast Cancer
Tata Memorial Hospital 800
Large-scale testing (Phase 3)Looking for participantsNCT01785420
What this trial is testing

Pre Operative Trastuzumab in Operable Breast Cancer

Who this might be right for
Carcinoma Breast Stage IHER2 Positive Breast Cancer
Dr Rajendra A. Badwe 1,100
Testing effectiveness (Phase 2)Study completedNCT00096343
What this trial is testing

Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Alabama at Birmingham 31
Not applicableStudy completedNCT03860740
What this trial is testing

Effect of Physical Exercise on Tumor Proliferation of Luminal B Breast Cancer Patients

Who this might be right for
Breast CancerLuminal B
Spanish Breast Cancer Research Group 12
Large-scale testing (Phase 3)Study completedNCT00312208
What this trial is testing

Docetaxel in Breast Cancer

Who this might be right for
Breast Cancer
Sanofi 3,299
Not applicableUnknownNCT03842176
What this trial is testing

Clinical Application of CTC in Operable Breast Cancer Patients

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 90
Large-scale testing (Phase 3)Study completedNCT00129935
What this trial is testing

EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 1,384
Testing effectiveness (Phase 2)Study completedNCT00530868
What this trial is testing

Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

Who this might be right for
Breast CancerCancer of the BreastBreast Neoplasm
University of Alabama at Birmingham 75
Not applicableLooking for participantsNCT03694756
What this trial is testing

TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

Who this might be right for
Breast Cancer
Montefiore Medical Center 95
Testing effectiveness (Phase 2)Study completedNCT03395899
What this trial is testing

Pre-operative Immunotherapy Combination Strategies in Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor-positive Breast Cancer
Queen Mary University of London 71
Large-scale testing (Phase 3)Study completedNCT00793377
What this trial is testing

Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer

Who this might be right for
Primary Breast Cancer
GBG Forschungs GmbH 913
Large-scale testing (Phase 3)Ended earlyNCT00908531
What this trial is testing

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

Who this might be right for
Operable Breast Neoplasms
Danish Breast Cancer Cooperative Group 123
Testing effectiveness (Phase 2)Study completedNCT00424203
What this trial is testing

Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCognitive/Functional EffectsDepression+2 more
UNICANCER 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03571633
What this trial is testing

Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer

Who this might be right for
HER2-positive Breast CancerOperable Breast Cancer
Centre Leon Berard 90
Large-scale testing (Phase 3)WithdrawnNCT05474690
What this trial is testing

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Henan Cancer Hospital
Large-scale testing (Phase 3)UnknownNCT00003679
What this trial is testing

Combination Chemotherapy in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
Scottish Cancer Therapy Network 350
Testing effectiveness (Phase 2)Ended earlyNCT00499681
What this trial is testing

PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 6
Large-scale testing (Phase 3)Study completedNCT01566721
What this trial is testing

A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Who this might be right for
Breast Neoplasms
Hoffmann-La Roche 2,577
Next Page